Wuhan Easy Diagnosis Biomedicine Co.,Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 537.56 million compared to CNY 5,253.23 million a year ago. Revenue was CNY 537.56 million compared to CNY 5,253.23 million a year ago.

Net income was CNY 112.57 million compared to CNY 2,760.4 million a year ago. Basic earnings per share from continuing operations was CNY 0.49 compared to CNY 12.07 a year ago. Diluted earnings per share from continuing operations was CNY 0.48 compared to CNY 11.92 a year ago.